F
11.58
0.73 (6.78%)
| Penutupan Terdahulu | 10.84 |
| Buka | 10.99 |
| Jumlah Dagangan | 224,807 |
| Purata Dagangan (3B) | 270,067 |
| Modal Pasaran | 402,081,152 |
| Harga / Pendapatan (P/E Ke hadapan) | 37.31 |
| Harga / Jualan (P/S) | 5.72 |
| Harga / Buku (P/B) | 8.81 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Aug 2026 |
| Margin Keuntungan | -46.71% |
| Margin Operasi (TTM) | -9.23% |
| EPS Cair (TTM) | -0.530 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -65.50% |
| Nisbah Semasa (MRQ) | 5.13 |
| Aliran Tunai Operasi (OCF TTM) | -16.39 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -9.65 M |
| Pulangan Atas Aset (ROA TTM) | -12.96% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Fennec Pharmaceuticals Inc. | Bercampur | Menaik |
AISkor Stockmoo
-1.0
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | -1.00 |
|
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 16.29% |
| % Dimiliki oleh Institusi | 57.51% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ANDRADE ROBERT | 9.57 | - | 1,703 | 16,298 |
| CIOFFI CHRISTIANA MARIE | 9.57 | - | 156 | 1,493 |
| EVANS TERRY L | 9.57 | - | 168 | 1,608 |
| HACKMAN JEFFREY S. | 9.57 | - | 1,159 | 11,092 |
| RAYKOV ROSTY | 9.57 | 9.59 | -7,222 | -69,315 |
| SAYAD PIERRE SARGIS | 9.57 | - | 168 | 1,608 |
| Jumlah Keseluruhan Kuantiti Bersih | -3,868 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -37,217 | |||
| Purata Pembelian Keseluruhan ($) | 9.57 | |||
| Purata Jualan Keseluruhan ($) | 9.59 | |||
| Julat Insider ($) | ||||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| RAYKOV ROSTY | 03 Aug 2026 | Jual automatik (-) | 10,000 | 9.59 | 95,900 | |
| RAYKOV ROSTY | 31 Jul 2026 | Diperolehi (+) | 2,778 | 9.57 | 26,585 | |
| ANDRADE ROBERT | Pegawai | 31 Jul 2026 | Diperolehi (+) | 1,703 | 9.57 | 16,298 |
| CIOFFI CHRISTIANA MARIE | Pegawai | 31 Jul 2026 | Diperolehi (+) | 156 | 9.57 | 1,493 |
| EVANS TERRY L | Pegawai | 31 Jul 2026 | Diperolehi (+) | 168 | 9.57 | 1,608 |
| HACKMAN JEFFREY S. | Pegawai | 31 Jul 2026 | Diperolehi (+) | 1,159 | 9.57 | 11,092 |
| SAYAD PIERRE SARGIS | Pegawai | 31 Jul 2026 | Diperolehi (+) | 168 | 9.57 | 1,608 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |